Oral glucose tolerance test values as a predictor of pharmacotherapy requirement in gestational diabetes mellitus

Read full text Summarise with VIRAT
Authors: Pooja Patil, Neha Singh, Smita Batni, Vartika Tiwari
Cited by: 0
References: 18

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance that is first recognized during pregnancy. It is associated with several adverse maternal and neonatal outcomes. Early identification of women likely to require pharmacotherapy beyond Medical Nutrition Therapy (MNT) may facilitate timely intervention and improved outcomes. Objective: To evaluate whether serum glucose levels during Oral glucose Tolerance Test OGTT can predict the mode of treatment required to achieve optimal glycemic control in women with GDM. Methods: This prospective cohort study included 120 women diagnosed with GDM by OGTT using IADPSG criteria at LN Medical College, Bhopal. Participants were categorized into 4 groups based on treatment required to attain optimal glycemic targets: I) MNT only, II) MNT + Metformin, III) MNT + Insulin, or IV) MNT + Metformin & Insulin. OGTT values were compared across these groups. Results: Women in Group II(n=27) had significantly higher 1-hour OGTT values than in Group I(n=83) (198±31.3 vs. 158±23.3 mg/dL, p=0.003). Group III (n=9) demonstrated significantly higher fasting (131±16.7 vs. 106±12.2 mg/dL, p=0.007), 1-hour (222±27.8 vs. 158±23.3 mg/dL, p

Fields of Study & Subjects

Gestational Diabetes Research and Management Pregnancy and Medication Impact Diabetes Management and Research

Publication details

Journal / source
International Journal of Clinical Obstetrics and Gynaecology
Volume
10
Issue
2
Pages
617–621
Publication date
1 March 2026
Language
EN